Rheumatology

Rheumatology

Endocrinology Today
May 2022
2022; 11(2): 17-25
Chronic musculoskeletal disorders due to FGF23-mediated hypophosphataemia
Terrence Diamond, Shejil Kumar
Endocrinology Today
May 2022
2022; 11(2): 8-15
Osteoporosis: enhancing management in primary care
MICHAEL BENNETT, Chris White, Lin Perry
Perspectives
Endocrinology Today
November 2021
2021; 10(4): 20-25
Anabolic therapy: a new paradigm for osteoporosis management
Albert S. Kim, Christian M. Girgis
Endocrinology Today
November 2021
2021; 10(4): 14-18
Optimising bone health during endocrine therapy for hormone sensitive cancer
Sabashini K. Ramchand, Nicholas Russell, Mathis Grossmann
Perspectives
Endocrinology Today
August 2021
2021; 10(3): 20-23
What’s new in assessing fracture risk?
Nicholas A. Pocock
Endocrinology Today
May 2021
2021; 10(2): 11-16
Secondary fracture prevention. Ensuring the first fracture is the last
Kirtan Ganda, Markus J. Seibel
Case studies
Endocrinology Today
October 2020
2020; 9(4): 29-31
Endocrine causes of osteoporosis. Part 3: Premature ovarian insufficiency
Madhuni Herath, FRANCES MILAT, PHILLIP WONG
Perspectives
Endocrinology Today
February 2018
2018; 7(1): 27-29
Osteoporotic fractures: what is the impact on mortality?
Weiwen Chen, Jacqueline Center
Perspectives
Endocrinology Today
February 2017
2017; 6(1): 17-20
New and emerging therapies for osteoporosis
MELISSA CLARKE, THOMAS DOVER, Emma Duncan
Perspectives
Endocrinology Today
October 2015
2015; 4(5): 31-34
Absolute fracture risk: what does it mean for your patient?
Weiwen Chen, Jacqueline Center
Case studies
Endocrinology Today
July 2012
2012; 1(2): 22-25
An older woman on bisphosphonate therapy who continues to fracture
Pat Phillips, Aimee Hayes, Terry Diamond